Community and research at the forefront of WM Forum
The importance of the WM community and patient-focussed research were the two key takeaways from the first ever European WM Patient…
New alliance will help drive Waldenstrom’s macroglobulinaemia research
WMUK is pleased to announce a new five year strategic alliance with Dendrite Clinical Systems, to
Wheels for Waldenstrom’s team pedal for glory
In August, 20 riders took on the incredible challenge of cycling from London to the heart of Paris to support the work of WMUK
A statement to our donors
Our donors mean the world to us. Without them, we can’t fund our Support Line, produce information or drive forward research. However,…
Shingles vaccine extended to cover vulnerable adults over the age of 50
The extended vaccination programme will roll out in September 2023.
Nigel Coupland is on a mission to raise vital funds for our charity
Nigel Coupland is raising money for our charity WMUK which helps those suffering from Waldenstrom’s macroglobulinemia.
Financial help for the WM community!
WMUK is thrilled to announce its first ever Patient Assistance Fund to help offer financial support to the WM Community.
Support Update
Support update from WMUK’s CEO, Jane Nicholson.
Meet the… Support Line and Education Manager
As part of a new series, we’re going to be meeting people from across the WM community.
COVID-19 Spring Boosters
The COVID-19 Spring booster programme for 2023 has now started. There will also be a further booster in Autumn 2023.